Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ephedrine and phenylephrine are sympathomimetic vasopressors used to manage intraoperative hypotension. This specific entry refers to a clinical trial (NCT01141374) conducted by University Hospital, Clermont-Ferrand, which compared the efficacy and safety of these two agents in patients undergoing carotid endarterectomy. Ephedrine acts as a non-selective agonist at alpha- and beta-adrenergic receptors and also promotes the release of endogenous norepinephrine, providing both vasoconstrictive and inotropic effects. Phenylephrine is a selective alpha-1 adrenergic receptor agonist that primarily increases systemic vascular resistance through potent vasoconstriction. The study aimed to determine if the pure alpha-adrenergic activity of phenylephrine might negatively impact cerebral perfusion compared to the mixed adrenergic profile of ephedrine during periods of accidental hypotension.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ephedrine + phenylephrine (Centre Hospitalier Universitaire de Clermont-Ferrand).